1[3]WU J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancerbinding protein beta element in the Fasl gene promotor alters Fas ligant expression;a candidate background gene in African American systemic lupus erythematosus [J].J Immunol, 1998, 170( 1 ): 132-138.
2Wang Liangchun, Bu Dingfang, Yang Yong et al. Castleman' s tumours and production of autobody in paraneoplastic pemphigus. Lancet,2004,363 : 525-531.
3Zhang X J, He P P, Wang Z X et al. Evidence for a major psoriasis susceptibility locus at 6p21 (PSORI) and a novel candidate region at 4q31 by genome-wide scan in Chinese Hans. J Invest Dermatol, 2000,119:1361-1366.
4Zhang X J, Wang H Y, Hsute Shao et al. Study on genetic epidemiology of psoriasis vulgaris in Chinese psoriatic patients. Int J Dermatol,2002,41:663-669.
5朱学骏.大疱病40年回顾与展望[J].中华皮肤科杂志,1993,26:67-69.
6Oelke K;Richardson B.Pathogenesis of lupus,2002.
7Takada K;Illei GG;Boumpas DT.Cyclophosphamide for the treatment of systemic lupus erythematosus[J],2001.
8Callen JP.Dermatomyositis:diagnosis,evaluation and management,2002.
9Hawk A.Localized and systemic scleroderma[J],2001.
